Video
Expert: Build Back Better Bill Would Give Federal Government Involvement on Drug Prices
Author(s):
Lindsay Bealor Greenleaf, MBA, JD, Vice President of ADVI Health, discusses a new poll from the Kaiser Family Foundation that found that 83% of Americans believe the government should be allowed to negotiate lower drug prices, for both those on Medicare and in private insurance plans.
In a Pharmacy Times® interview, Lindsay Bealor Greenleaf, MBA, JD, Vice President of ADVI Health, discussed a new poll from the Kaiser Family Foundation that found that 83% of Americans believe the government should be allowed to negotiate lower drug prices, for both those on Medicare and in private insurance plans.
She mentioned how the federal government is currently involved in drug prices, how the Build Back Better reconciliation bill would affect the federal government’s involvement, and how this would affect individuals under Medicare and those under private insurers.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
